Waaree Energies delivered a robust Q4 with 112% revenue growth and 71% profit growth. Despite a contraction in EBITDA margins, the company's forward-looking guidance remains highly optimistic, targeting up to ₹7,700 crore in EBITDA by FY27.
Market snapshot: Waaree Energies has reported a stellar performance for the final quarter of the fiscal year, driven by massive scale-up in solar module shipments and domestic demand. While top-line and bottom-line growth exceeded 70%, the company is now pivoting toward aggressive long-term targets, projecting significant EBITDA expansion by FY27.
Summary: Waaree Energies delivered a robust Q4 with 112% revenue growth and 71% profit growth. Despite a contraction in EBITDA margins, the company's forward-looking guidance remains highly optimistic, targeting up to ₹7,700 crore in EBITDA by FY27.
Waaree's results confirm its leadership in the Indian solar module space. The slight margin dip is a secondary concern compared to the sheer volume growth and the clarity of the FY27 roadmap. The market is likely to focus on the 'operating leverage' potential as the company hits its guided ₹7,000+ Cr EBITDA marks.
The solar sector remains a high-conviction area for capital allocation. Waaree’s growth signals strong tailwinds for EPC players and raw material suppliers in the solar value chain. Institutional interest is expected to remain high given the clear earnings visibility provided by management.
Market Bias: Bullish
Revenue growth of 112% and a clear path to ₹7,700 Cr EBITDA by FY27 support a strong positive bias despite the 446 bps margin compression.
Overweight: Solar Manufacturing, Renewable Energy EPC, Power Infrastructure
Underweight: Fossil Fuel Utilities
Trigger Factors:
Time Horizon: Medium-term (3-12 months)
The Indian solar industry is benefiting from domestic content requirements (DCR) and the Approved List of Models and Manufacturers (ALMM). As India aims for 500GW of non-fossil capacity by 2030, players like Waaree are essential to meeting domestic supply shortfalls.
Waaree Energies successfully completed its IPO in late 2024 and has since focused on expanding its US manufacturing footprint. In the last 60 days, the company has secured multiple green hydrogen-linked power supply agreements and ramped up its cell manufacturing facility to reduce dependence on imports.
Waaree Energies is no longer just a domestic player; it is scaling to become a global solar powerhouse. While the margin dip requires monitoring, the trajectory toward ₹7,700 crore EBITDA makes it a core monitorable for any green energy portfolio.
The margin fell to 18.58% from 23.04% primarily due to increased raw material costs and operational overheads associated with rapid capacity scaling. Management expects this to stabilize as higher-capacity plants reach optimal utilization.
The guidance of ₹7,000–7,700 crore in EBITDA by FY27 implies a significant growth CAGR from current levels. This forward-looking data point allows institutional investors to model earnings with higher confidence, potentially supporting a valuation premium compared to slower-growing peers.
Waaree's 112% revenue jump signals that the 'Make in India' push in renewables is yielding results. It sets a high benchmark for other domestic manufacturers and suggests that domestic module supply is finally matching the massive pace of Indian solar installations.
High Performance Trading with SAHI.
Related
JPMorgan Downgrades Apollo Tyres: Navigating Commodity Headwinds and Sector Re-rating
JPMorgan Bullish on TVS Motor: Target Price Hiked to ₹4,440 as Resilience Outshines Sector Risks
JPMorgan Shifts Stance on Escorts Kubota: Upgrade to Neutral Amid Sector Recalibration
Geopolitical Friction in Hormuz: Oil Majors Flag Costs of Proposed Tolls and India’s Readiness Gaps
Recent
Indegene Targets EBITDA Margin Recovery to 22% by H2 FY2027 via Strategic Biopharm Integration
Bajaj Finance Q4 Profit Jumps 22% to ₹54.64b as Lender Eyes 4.6% ROA
Biocon Bengaluru Plant Receives 5 US FDA Procedural Observations with Zero Data Integrity Issues
SPARC Sells Priority Review Voucher for $195 Million to Fund R&D Pipeline